EP139: How do you Lead Innovation with Roy Rosin, Chief Innovation Officer at U of PA, Penn Medicine
June 08, 201741:51

EP139: How do you Lead Innovation with Roy Rosin, Chief Innovation Officer at U of PA, Penn Medicine

Roy Rosin is Chief Innovation Officer at Penn Medicine, working to rapidly design, test and implement high impact health care delivery practices. His team crafts interventions to achieve dramatically improved patient outcomes, experience and high value care. In the past four years they have driven measurable progress in readmission rates, frequent use of the ER, medication adherence, screening rates, antibiotic stewardship and making a population normotensive, among other advances.

Previously, Roy served as the first VP of Innovation for Intuit, a leading software company best known for Quicken and TurboTax. In this role, he led changes in how Intuit managed new business creation, allowing teams to experiment quickly at low cost.  Intuit now consistently appears on Forbes' list of the most innovative companies in the world.

Prior to leading innovation, Roy’s Quicken team achieved record profitability and product leadership while growing to 14 million consumers. Roy's 18 years with Intuit spanned the early years in software to their emergence as a leading SaaS provider.

Outside of his Penn role, Roy advises startups and Fortune 100 companies building new technology businesses focused on making a meaningful difference in people’s lives.

Roy received his MBA from Stanford and graduated with honors from Harvard College.


00:00 Leading Innovation.
02:30 The challenges of creating Innovation.
04:45 Allocating Innovation.
05:05 “Innovation is a set of methods, or a way of doing work.”
07:40 Reconciling ‘Tops Down, Bottoms Up.’
10:50 “We’re not married to a Solution, we’re married to the Outcome.”
11:20 “Fall in love with the problem.”
13:30 Deciding which projects to proceed with, whether the metrics are there or not.
18:00 Connect Health.
27:15 Fast failing, collecting Success Metrics and deciding how to evaluate an experiment.
30:00 Measuring Activity, Engagement, and Results.
35:00 “Impact is the goal.”
35:15 “You're going to almost always start in the wrong direction.”
36:20 “How do you know you got it right?”
37:30 Roy’s three-part model.
41:00 Find out more information at https://chti.upenn.edu/.

healthcare,health,marketing,innovation,penn medicine,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, Steven Elkins, Matthew Bunte, Lori Smith, Dr. Scott Conard, Vivian Ho and Casey Cormier

Recent Episodes

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone
Relentless Health ValueOctober 28, 2026
535
37:1834.15 MB

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone

LIsten on Your Favorite App On episode 532 a few weeks ago, Chris Klomp from HHS was talking about ER (emergency room) usage as a signal, not just a statistic. If too many folks show up in the ER, consider this a signal that there's something missing. It means a patient who doesn't have access to pr...

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson
Relentless Health ValueOctober 21, 202608:538.13 MB

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson

Listen On Your Favorite App Here's a question I have heard more than once: What is a practical, speedy way to assess whether a TPA (third-party administrator) is truly independent and willing to protect the plan's interests, this plan sponsor's interests, versus being captive to, for example, networ...

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD
Relentless Health ValueSeptember 16, 2026
529
39:2936.14 MB

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Hey, thanks for being here with me every week, some of you every single Thursday. Give yourself a little round of applause, maybe silently and in your own head, depending on where you are. But yeah, you matter. You being here matte...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.